from the interwar period, and its role in the influential developments in molecular biology from the 1950s on. As a prominent scientist alert to the opportunities provided by the growing interest in nucleic acid, Ochoa sought to keep enzymology at the core of biomedical developments in the postwar period. His emphasis on the primacy of enzymes helped define the promise of contemporary molecular biology and, more broadly, biomedicine; polymerases and, later, restriction enzymes played an increasing role as both the tools and the objects of inquiry in genetic engineering. 1 This essay discusses Ochoa's contributions to the consolidation of biochemistry and molecular biology as scientific disciplines in Spain. I consider biochemistry and molecular biology together. They were established in Spain as closely related disciplines-both cognitively and institutionally-although biochemistry was introduced slightly earlier. As a result, biochemistry contributed to the delineation of molecular biology even as the two fields were differentiated somewhat. The rhetoric that kept them separated in research centers in other countries-where the distinction was often drawn by the most influential of the self-described molecular biologists-was to some extent circumvented in Spain by Ochoa's particular scientific trajectory.2 International recognition, which came first, drew attention to the work of young Spanish researchers who were trying to build careers. Ochoa served as a particularly influential agent of recognition. As a distinguished representative of research done in the United States by a Spanish-born scientist-he obtained U.S. citi-biochemical approaches began to spread and become influential among medical and biological researchers and science policy makers in Spain. 5 At the same time, other conditions were changing as well. During the 1950s Spain began to rebuild its international relationships, departing from the autarky that had characterized the early years of Franco's rule. In 1959 new economic measures were put into force, with far-reaching consequences for Spanish science. 6 This essay argues that a combination of national and international influences-the Nobel award to a Spanish-born scientist, a receptive research community, and a government increasingly inclined to reassert itself on the international stage-together facilitated a special emphasis on biochemistry and molecular biology in the reconstruction of Spanish science after 1959.7 I begin with a brief description of Severo Ochoa's scientific achievements prior to his reception of the Nobel Prize. Then I analyze three "events" related to his research that influenced the emerging Spanish community of biochemists and molecular biologists. The first is the notice accorded Ochoa's Nobel Prize in the country of his birth and some of its immediate consequences, such as celebratory publications, national conferences on biochemistry, and the creation of the Sociedad Espafiola de Bioquimica. The second is an international meeting on biochemistry held in Madrid in 1969, following the deciphering of the genetic code-work to which Ochoa made a key contribution. The third is the International Symposium on Enzymatic Mechanisms in Biosynthesis and Cell Function, held in Barcelona and Madrid in 1975, after Ochoa retired from the New York University School of Medicine, to honor him on his seventieth birthday.
Linked by the presence and influence of a singular scientific leader, these celebrations and commemorations illuminate Ochoa's role in advancing Spanish science to the present day.8 Though the influence of this distinguished actor should not be minimized, it was not the only factor at work. Analysis of almost two decades of research, training, and policymaking practices in Spanish biomedicine reveals a complicated series of agendas; Ochoa's influence cannot be understood without considering the political and scientific context of its reception.
SEVERO OCHOA: FROM PHYSIOLOGY TO POLYNUCLEOTIDES
From the early days of biochemistry at the end of the eighteenth century (and well before the term "biochemistry" was used), its central problem was to determine the stages by which foodstuffs are broken down in the animal body. Further work to elucidate the 5 Returning to Meyerhof's laboratory in Heidelberg, Ochoa worked on glycolysis in heart muscle, on the isolation of pure cozymase-the muscle fraction known to intervene in glycolysis-from skeletal muscle, and on transphosphorylation in muscle extracts. By this time the laboratory had turned to biochemistry: glycolysis and fermentation in muscle or yeast extract and partial reactions catalyzed by purified enzymes were the main subjects of investigation. In 1937, with Germany under the control of the Nazis, Meyerhof left for Paris. He arranged a six-month fellowship for Ochoa at the Marine Biological Laboratory in Plymouth (U.K.); from there Ochoa moved on to the Oxford biochemistry department to work with Rudolph A. Peters on the role of vitamin B1 (thiamine) and cocarboxylase (pyrophosphate ester of thiamine) in pyruvate oxidation. The work was very productive: they established that cocarboxylase, rather than thiamine, was the cofactor for pyruvate oxidation in pigeon brain and showed a requirement for adenine nucleotides that suggested a coupling of oxidation and phosphorylation. But once more a period of promising work was cut short, this time by World War II: Peters's whole lab became involved in war work, and Ochoa, as a foreigner, had to leave.'3
In August 1940 Ochoa left Europe. By this time, his investigative move from physiology to biochemistry had already taken place. In addition to his work under Meyerhof on the energetics of muscular contraction, Ochoa had explored the role of the adrenal glands in 1932-1933, when he joined Dudley in London. He had moved on to glycolysis and fermentation in heart muscle when he returned to Madrid before the outbreak of the Civil War and had continued this work in Berlin, in addition to transphosphorylation studies on muscle extracts. Working with brain homogenates in Oxford, he had found "that the oxidation of pyruvate in brain homogenates, in the presence of catalytic amounts of AMP or ATP, was coupled with the phosphorylation of hexosemonophosphate or glucose."''4
In 1940, after some weeks in Mexico City, Ochoa joined Carl Cori at his laboratory at the Washington University School of Medicine in St. Louis, where he hoped to contribute to the enzyme and phosphorylase research of the group. Herman Kalckar, Earl Sutherland, and Sidney Colowick were also at Washington. Unfortunately, all Ochoa's efforts to show, as Cori proposed, "that fructose-I-phosphate would be converted to fructose-6-phosphate, either of which would then form glucose-6-phosphate, were in vain. To make matters worse there was a rather large accumulation of inorganic pyrophosphate along with fructose-l-phosphate. I left the Cori laboratory a bit frustrated having explained nothing."' 5 He had, however, learned a great deal about the practice of enzymology. 12 Ochoa, "Pursuit of a Hobby" (cit. n. 10), pp. In 1942 Ochoa moved to New York University as a research associate in medicine, thanks to the support of NYU nutritionist Bob Goodhart, whom Ochoa had met during his stay in Peters's laboratory in Oxford. It would be at NYU, where he worked until his retirement, that Ochoa produced most of his scientific work that contributed to the development of biochemistry and, subsequently, to the deciphering of the genetic code. Ochoa began by returning to the problem of oxidative phosphorylation-a mechanism whereby energy is made available from biological oxidation-on which he had first worked at Oxford. He concluded in 1943 that the atomic ratio of phosphorus esterified to oxygen consumed (P/O ratio) of pyruvate oxidation was 3, a finding later confirmed by Albert L. Lehninger using mitochondria. Building on his earlier research in Europe, Ochoa resumed his studies of transphosphorylation and consumption of oxygen, this time in heart homogenates. Interest in Hans Krebs's proposal of a citric acid cycle as the main pathway for the oxidation of foodstuffs led Ochoa to study the enzymes involved.'6
In 1946 Ochoa was appointed chairman of the NYU Department of Pharmacology at the suggestion of the English biophysicist Keith Cannan, the chairman of the Department of Biochemistry where Ochoa had had a laboratory space. Ochoa was only the second biochemist to be named a professor of pharmacology-"since Cori was the first I was in good company." He succeeded James A. Shannon, who had just been invited to join the National Institutes of Health.'7 In 1954 Ochoa moved to the chair of the Department of Biochemistry. During the intervening years he worked on the citric acid cycle and related metabolic pathways. It has been said that "he adopted a clearly enzymological approach. Since each step of the process should be catalyzed by a specific enzyme, one must isolate each enzyme in order to clarify the mechanism. Some of the enzymes were already known, but none had been isolated to a sufficient degree of purity." Ochoa's research on intermediary metabolism-including pyruvic acid oxidation, the reversible conversion of oxaloacetate into citrate, the formation of oxalosuccinate and alpha-ketoglutarate, the oxidation of alpha-ketoglutarate and the malic enzyme-brought him into prominence among the core enzymologists.18 He also conducted research on fatty acid metabolism through the metabolism of propionic acid and investigated topics in photosynthesis as they related to the light dependence of reductive carboxylation of pyruvate to malate. Enzymological questions also prompted the identification of the new polymerization enzyme polynucleotide phosphorylase in Ochoa's lab-work accomplished by his French postdoctoral fellow Marianne Grunberg-Manago when studying the mechanism of oxidative phosphorylation in extracts of the highly aerobic bacteria Azobacter vinelandii. We know from Grunberg-Manago's account of her work on this problem that, at Ochoa's suggestion, she was trying to isolate a system for ATP synthesis linked to oxidation. She decided to investigate the exchange reaction between phosphate and ATP in A. vinelandii and tried to isolate "interesting new coenzymes." She realized, however, that the ADP impurity of the amorphous ATP was the active component of phosphate exchange. A few months later Grunberg-Manago noted that she was dealing not only with an exchange reaction but with a reaction in which active phosphate was liberated; its product was a high-molecular-weight compound that she identified as a polynucleotide. The product was characterized with the help of Leon Heppel, Jacques Fresco, and Alexander Rich, and Grunberg-Manago was able to synthesize ribonucleic acids very similar to biological RNA. Grunberg-Manago and Ochoa described the reversible reaction catalyzed by PNPase as n X-R-P-P a n (X-R-P) + n P, where R stands for ribose; X may be adenine, hypoxanthine, guanine, uracil, or cytosine; and P is the phosphate group. This was the first time that a polyribonucleotide was produced in a test tube, and the work attracted considerable attention.20
The Spanish scientists who worked abroad were asked to offer suggestions. They were expected to contribute ideas on the new system as a whole and also to make specific program recommendations with reference to their particular fields (it was hoped that responsiveness to the suggestions might eventually work to entice these scientists to return to Spain). Among the first to be contacted were the neuroscientist Jose Manuel Rodriguez Delgado, the physicist Nicolas Cabrera, and Ochoa. In 1968 Ochoa was visited by Ricardo DiezHochleitner, the undersecretary of the ministry of education and a UNESCO official on leave; he was persuaded to accept the chairmanship of the committee that was to discuss 41 after serving as Spanish minister of education and science), David Vaizquez, Gertrudis de la Fuente (a close collaborator of Sols), and Angel Santos Ruiz (professor of physiology and biochemistry at the University of Madrid School of Pharmacy) were all on the organizational committee. At the end of January, however, a nationwide state of emergency that would last for three months was declared following student demonstrations that closed the universities of Madrid and Barcelona. There was disagreement concerning this measure in the Cabinet; some ministers and top officials regarded it as too harsh. Up to two hundred students and professors were expelled from the universities, and a student, Enrique Ruano, died in police custody in Madrid. Although the authorities claimed he committed suicide by jumping from a third-floor window, suspicions about the death helped to intensify forbidden demonstrations and the occupation of churches in expression of solidarity with the imprisoned. The crisis was particularly unfortunate for the monarchic elite, who were working hard to ensure that the young prince Juan Carlos de Borbon would succeed Franco on his death; it was not possible to announce the planned succession while the country was under a state of emergency.50
The state of emergency also affected plans for the forthcoming FEBS meeting. In February faculty members of the University of Konstanz strongly suggested that the meeting be canceled "in view of the latest dictatorial acts in Spain." Some member biochemical societies discussed the Spanish political situation and even voted as to whether they would take part in the meetings: French, Dutch, and Swedish scientists were most active in expressing discomfort. The secretary-general of the FEBS, H. V. R. Arnstein, and the treasurer, Prakash Datta, visited Madrid in February to evaluate the situation for themselves; on returning to London, they recommended that, "unless the Spanish political situation suddenly and seriously deteriorates, the meeting should go on as planned." Apparently things were calmer at the experimental science centers than at the universities. The former were described as "untroubled," and, although teaching had come to a halt, research work and training continued. Spanish authorities guaranteed the biochemists access to the meeting. Even before the state of emergency was suspended at the end of March, the representatives issued a report of their visit stressing that the FEBS was a nonpolitical organization and offering criteria for "the practicability of a scientific meeting in a delicate situation"-primarily participants' freedom of speech and movement.51 Assurances aside, some speakers and session chairs refused to take part in the Madrid meeting, and in the last month and a half Sols was forced to make numerous international telephone calls to find substitutes. In the end, the meeting was held as planned from 7 to 11 April. recognized as within the domain of molecular biology, and enzyme research offered experimental validation of the hypothesis derived from DNA structure: that genetic information is transmitted from nucleic acids to proteins.114As a consequence, a renaming of biochemists' concerns and research fields took place, and some of them adopted the term "6molecular biology," suggesting that no apparent difference existed between the latter and biochemistry.6 Some biochemists, concluding that no real differences existed between the two fields, reoriented the description of their interests and research problems. The symposium paid tribute not to a single discovery but to Ochoa's entire scientific career. Enzymology was emphasized-both in Ochoa's original research and as an important tool for later lines of work. For example, polynucleotide phosphorylase was acknowledged both as an important enzymological achievement and because it became a tool for elucidating the genetic code. Viewed retrospectively, Ochoa's scientific achievements-from the physiological chemistry of muscle contraction to his work on the genetic code-led him to the core of biochemistry and then on to molecular biology, a trajectory epitomizing the historically central role of enzymology in contemporary biomedical sciences. The symposium for Ochoa should be viewed as an episode in the ongoing debate between biochemists and molecular biologists as to the roles of their respective disciplines in the development of contemporary biology, a debate that was exacerbated in 1961, when Nirenberg presented his first results on deciphering the genetic code. From the earliest days of their discipline, the approach of the self-described molecular biologists was marked by theories or hypotheses whose verification relied on biochemical labor-or so the biochemists thought. This representation at the symposium fails to make it clear, however, that Ochoa had not contributed to the beginnings of molecular biology: enzymologists were not "members of the club" of molecular genetics, nor were they much concerned with the regulation of biological processes. At the end of the 1950s, in the second decade of the Franco dictatorship, Spain revived its scientific research by enabling a small group of young experimentalists to study abroad: as they became familiar with biochemistry and molecular biology as they were practiced in other parts of the world, their own research approaches changed. But they were able to have an effect at home-through the establishment of these disciplines in the research and training structures of Spanish science-only within the framework of the national political context.
After 1959, the young community of Spanish biochemists took advantage of Ochoa's Nobel Prize award. In the protective shadow of the recognition he won, they were able to stress the role of biochemistry in research and teaching and to claim an academic space for themselves apart from established disciplines whose authorities were, they believed, unwilling or unable to appreciate the new contributions. Just as important to the influence of Ochoa was the prevailing nationalistic spirit of early Francoism. Press policies and censorship practices both favored presentations that focused on the distinguished recognition afforded by the Nobel award. Only a few public accounts mentioned that Ochoa had pursued his scientific career in the United States, a focus that would have raised uncomfortable questions about budgetary and political support for Spanish science. By insisting that he could have won a Nobel Prize even had he remained in Spain, popular accounts stressed nature over nurture. This perspective also suited the official discourse that emphasized Spanish national capability in general and aptitude for science in particular.
As the new generation of scientific researchers consolidated their resources, they joined to create their own society for biochemistry. They emphasized their indebtedness to Ochoa; at the same time, they celebrated the international recognition he had won as a core member of the enzymological community. Yet in 1963, the year the Sociedad Espaniola de Bioquimica was formed, Ochoa himself was very much engaged in molecular biology. The meeting organizers, probably unaware of the direction of his recent work, again focused on his contribution to metabolic (biochemical) topics.
At the time of the sixth FEBS meeting in 1969 Ochoa was deeply involved in molecular biological research pertaining to protein synthesis and the decoding of DNA as information. The field of molecular biology was thus in a position to benefit from changing circumstances in Spain: the projects for institutes of molecular biology in Barcelona and Madrid, established as part of the 1970 agreement between Spain and United States, were among the fruits of these developments. Ochoa's work on protein synthesis, one of the main topics of the FEBS meeting, was treated in a three-session symposium with contributions by three Spanish scientists. Even so, enzymes retained a central role: two symposia and a colloquium were devoted to enzymological topics.
As Ochoa approached his seventieth birthday, enzymes remained at the core of his work. The debate between biochemists and the first self-described molecular biologists and structuralists reflects how knowledge develops: previous knowledge eventually becomes a tool for some scientists but continues to define disciplines for others. Enzymes were tools for molecular biology, but they remained essential objects of inquiry for biochemists, who considered them vital for further research-as the contributors to Ochoa's birthday symposium showed. Ochoa's transition from biochemistry to molecular biology may well explain the smooth introduction of molecular biology into Spain, which took place under his influence. The ceremonies celebrating Ochoa's seventieth birthday, held in Barcelona and Madrid in 1975, focused on aspects of his scientific career from physiology to microbiology; biochemical issues were once again a focus, as the invited speakers fixed on enzymology as the central subject in Ochoa's lifelong work. This perspective connected the 1975 symposium to other recent debates and to celebrations of other chemists, at a time when the central role of molecular biology was being acknowledged in settings like the Asilomar Conference on the social implications of genetic engineering.
It would be too simplistic to assign Ochoa the main role in the establishment of biochemistry and molecular biology in Spain; it would also be a mistake to overlook his importance. National circumstances were influential indeed. As time passed, the growing Spanish community of biochemists and molecular biologists was very ready-and increasingly able-to draw on Ochoa's leadership and example whenever national conditions seemed to offer an opportunity to improve the situation of their disciplines.
